|
|
Volumn 128, Issue SUPPL. 1, 2011, Pages S1-
|
|
Aripiprazole: Striving towards euthymia with a novel mechanism of action
a,b,c
|
|
Author keywords
Bipolar disorder; Metabolic syndrome
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
BUSPIRONE;
DOPAMINE 2 RECEPTOR;
LITHIUM;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
SEROTONIN 1A RECEPTOR;
SEROTONIN 7 RECEPTOR;
SEROTONIN UPTAKE INHIBITOR;
VALPROIC ACID;
ADJUVANT THERAPY;
ANXIETY DISORDER;
ATARAXIA;
BIPOLAR DEPRESSION;
BIPOLAR DISORDER;
COMORBIDITY;
DEPRESSION;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
EDITORIAL;
EUTHYMIA;
FOOD AND DRUG ADMINISTRATION;
HEALTH HAZARD;
HUMAN;
MAINTENANCE THERAPY;
MANIA;
MENTAL DISEASE;
METABOLIC SYNDROME X;
MONOTHERAPY;
MOOD DISORDER;
NEUROBIOLOGY;
NEUROPHARMACOLOGY;
OBESITY;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
SIDE EFFECT;
SOMNOLENCE;
TRANQUILIZING ACTIVITY;
TREATMENT OUTCOME;
WEIGHT GAIN;
|
|
EID: 78651229469
PISSN: 01650327
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-0327(10)00742-1 Document Type: Article |
|
Times cited : (3)
|
|
References (1)
|
